Maria Agemark
Directeur/Membre du Conseil chez GFM Förvaltning AB
Profil
Maria Agemark is currently a Director at GFM Förvaltning AB.
Previously, she worked as a Deputy Director at ApoGlyx AB and as a Chief Operating Officer at SenzaGen AB from 2015 to 2021.
She has an undergraduate and doctorate degree from the University of Lund.
Postes actifs de Maria Agemark
| Sociétés | Poste | Début |
|---|---|---|
| GFM Förvaltning AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Maria Agemark
| Sociétés | Poste | Fin |
|---|---|---|
| SENZAGEN AB | Directeur des opérations | 01/03/2015 |
ApoGlyx AB
 ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden. | Corporate Officer/Principal | - |
Formation de Maria Agemark
| University of Lund | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SENZAGEN AB | Health Technology |
| Entreprise privées | 2 |
|---|---|
| GFM Förvaltning AB | |
ApoGlyx AB
ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden. | Health Technology |
